Erin S. Enright - Jan 14, 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Director
Signature
/s/ Erin. S. Enright
Stock symbol
ERNA
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 08:46 PM
Previous filing
Jan 5, 2022
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +67K $0.00 67K Jan 14, 2022 Common Stock, par value $0.005 per share 67K $3.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests (subject to continued service) with respect to 22,336 shares of common stock on the first anniversary of the grant date and then in subsequent monthly installments of 1,861 shares of common stock through the three-year anniversary of the grant date.